Corteva Q4 sales up 7%, loss narrows; full-year sales down 2%
Corteva reported fourth-quarter 2024 net sales of $4.0 billion, up 7% from a year earlier, and a GAAP loss from continuing operations of $50 million, smaller than the $231 million loss in the prior-year quarter. For full-year 2024, net sales fell 2% to $16.9 billion and GAAP diluted EPS from continuing operations was $1.22, down from $1.30, while the company refined its 2025 net sales and Operating EPS outlook for currency effects and expects to repurchase about $1 billion of shares in 2025.
Key points
- Q4 2024 net sales were $3,978 million, up 7%; Q4 GAAP loss from continuing operations was $50 million versus $231 million a year earlier.
- Full-year 2024 net sales were $16,908 million, down 2%; GAAP diluted EPS from continuing operations was $1.22 versus $1.30 in 2023.
- 2025 guidance: net sales of $17.2 billion to $17.6 billion and Operating EPS of $2.70 to $2.95 per share, refined for the stronger U.S. dollar.
- The company expects to repurchase approximately $1 billion of shares during 2025 and records approximately $150 million to $165 million in 2025 restructuring charges.
The filing
Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.